Navigation Links
Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
Date:12/8/2008

icals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

     Contacts:  Jack Lief                             Mary Claire Duch
                President and CEO                     WeissComm Partners
                                                      Media Relat
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
2. Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
3. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
4. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
5. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
6. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
9. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
11. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe’s ... expertise to the Los Angeles County clinics including ... procedures are now being offered at all Healthpointe ... County, and San Bernardino County. , As ... neurons send electrical impulses throughout the body ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe is ... Joint Fluid Therapy (JFT) at their clinics in Orange ... injectable treatment that assists in diminishing pain for patients ... Dr. Stanley Katz and Dr. Neil Katz of Healthpointe. ... sodium hyaluronate (also known as hyaluronic acid) a natural ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 For the ... (USAU) to bring the Denver youth ultimate community an opportunity ... learning and individual improvement. The mission of the USAU Nike ... boys and girls to improve, build character, and make lifelong ... for boys and girls of all skill and ability levels, ...
(Date:5/29/2015)... News: 2015-2016 Oil Market Forecast, Company: Carson Energy, ... , In July, 2014, the price of oil ... US shale production and increased production from Saudi Arabia. ... from US shale producers, started producing close to their ... into the marketplace, they could push oil prices below ...
(Date:5/29/2015)... May 29, 2015 Wimbledon Health Partners, ... electrocardiogram (EKG), echocardiogram and NCV testing, is proud ... guidelines for EKG interpretation of athletes. ... of death during athletic activity. New findings presented in ... discussion to improve cardiac safety in athletes. Physiologic adaptations ...
Breaking Medicine News(10 mins):Health News:Healthpointe Is Now Offering EMG and NCV Diagnostics at All Clinics throughout Southern California. 2Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:US Sports Camps, Nike Sports Camps, and USA Ultimate Host Third Summer of Ultimate Camp in Denver 2Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3
... Institute of Medicine recommends ways to avert an impending health care ... number of health care workers with the skills to meet their ... older by 2030 as the baby boom generation ages. The ... do to ensure that older Americans get the best care possible. ...
... 11 /Xinhua-PRNewswire-FirstCall/ -- Linkwell,Corporation (Linkwell) (OTC Bulletin ... of healthcare related disinfectants in China,announced today ... Hi-Tech Company, Ltd., (LiKang Disinfectant) was selected ... Ministry of Human Resources and,Social Security (MOHRSS) ...
... to evaluate palpable breast lesions, they can rule out ... conducted by researchers at Baystate Health in Springfield, MA. ... protocol. , We were interested in finding out ... together, in excluding breast cancer in women with palpable ...
... Registration is now,open for CleanMed 2008, ... practices and green building. The event is,produced ... Harm,along with partners Consorta, the Heinz Endowments, ... Center., CleanMed attracts major health care ...
... Set for June as Plan Moves Forward, HARRISBURG, ... provide input on Pennsylvania,s new State Plan on Aging., ... to help the,Department of Aging prioritize the needs and ... wellness and fitness programs, legal,assistance, and long-term living options. ...
... cancer patients who had an MRI examination before their initial ... out of Yale University School of Medicine. , ... treatment and 374 who did not undergo an MRI examination. ... Carol Lee, MD, an author of the study, now at ...
Cached Medicine News:Health News:Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics 2Health News:Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics 3Health News:Mammography plus sonography can help rule out breast cancer in patients with palpable lesions 2Health News:Creating Healing Environments: Healthcare Industry's Largest Sustainability Conference to be Held May 20-22 in Pittsburgh 2Health News:April 15 is Deadline for Input on State Aging Plan 2
(Date:5/28/2015)... MOUNTAIN VIEW, Calif. , May 28, 2015  IRIDEX ... Officer and Chief Financial Officer James H. Mackaness ... Wednesday, June 3, 2015, at 9:00 am PT in ... webcast of the presentation may be accessed on the Event ... www.iridex.com .  A replay of the webcast will be available ...
(Date:5/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/pph6hl/united_states ... "United States Medical Adhesives Market Forecast and Opportunities, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , The market ... States is projected to register 9% ... manufacturers across the US are expanding their production ...
(Date:5/28/2015)... The Parenteral Drug Association (PDA) proudly ... of the Johnson & Johnson Kilmer Conference on ... Johnson & Johnson (J&J) is reviving the conference ... endoscopes. J&J ran 8 conferences on sterilization, validation ... on advances in sterilization and other topics. ...
Breaking Medicine Technology:United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
... VEGAS, June 27, 2011 Gamma Pharmaceuticals, Inc. (NASDAQ: ... own branded products through wholesalers and direct to retailers, ... Company has completed a sale and revenue collection cycle ... Company,s energy gel products to a Northeast distribution center ...
... Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today ... based on tumor reprogramming will be presented at the ... 14th World Conference on Lung Cancer meeting ( www.2011worldlungcancer.org ...   "The data presentations from both lung ...
Cached Medicine Technology:Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain 2Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain 3Syndax Pharmaceuticals Announces Entinostat Data from Two Lung Cancer Clinical Trials at Upcoming World Lung Conference 2Syndax Pharmaceuticals Announces Entinostat Data from Two Lung Cancer Clinical Trials at Upcoming World Lung Conference 3Syndax Pharmaceuticals Announces Entinostat Data from Two Lung Cancer Clinical Trials at Upcoming World Lung Conference 4
... Rapid Toxin A Test gives your laboratory clear-cut ... it might be C. difficile, you can't afford ... a few tests a day or sends out ... Toxin A C. difficile Rapid Toxin A Test ...
... C. Diff A is a ... qualitative detection of Clostridium difficile ... , ,Clearview C. Diff A ... to provide fast, accurate detection ...
... come back with better resolution, accuracy and ... 25 or 31 rings (same as TMS-1), ... provides high accuracy & repeatability. The small ... & provides extensive corneal coverage. The low ...
... The OCULUS Pachycam is the first ... built-in keratometer. The OCULUS Pachycam ... (intra ocular pressure) in accordance with ... "real IOP. The OCULUS Pachycam ...
Medicine Products: